Vaginitis is a common gynaecological condition characterised by abnormal vaginal discharge, mal-odour, itching, burning and discomfort. The predominant forms include bacterial vaginosis (BV), vulvovaginal candidiasis (VVC) and trichomoniasis, while non-infectious forms may arise from atrophy, irritants, allergies or inflammation. BV is associated with reduced Lactobacillus populations and overgrowth of anaerobic bacteria, whereas VVC is commonly caused by Candida albicans. Trichomoniasis is a sexually transmitted infection caused by Trichomonas vaginalis.
Recurrence and persistent symptoms can complicate management, prompting interest in complementary therapies. Ayurveda approaches similar manifestations through concepts such as Yonivyapada and Shwetapradara. However, traditional interventions must be evaluated alongside established diagnostic and treatment standards.1
Ayurvedic understanding and management
Vaginitis is not described as a distinct disease entity in classical Ayurveda; instead, its manifestations may be interpreted within different Yonivyapada (gynaecological disorders) and Shwetapradara (white vaginal discharge) presentations. Pathogenesis is traditionally attributed to Dosha Dushti, involving Vata, Pitta and Kapha, with particular importance assigned to Apana Vata, which governs pelvic functions, menstruation and reproductive processes.
- Traditional management is individualised according to the symptoms and presumed dosha involvement.
- Vata-shamana measures, including Snehana (oleation), Svedana (sudation) and selected Shodhana procedures, have been described.
- Local interventions include Yoniprakshalana (vaginal cleansing or irrigation), Yonipichu (application of medicated tampons) and Yoni Varti (medicated vaginal suppositories). Other procedures, such as Parisheka (therapeutic streaming) and Pralepana (topical application), have also been discussed in traditional practice.
Herbal interventions and clinical evidence
Clinical studies have investigated oral formulations and local Ayurvedic preparations for symptom relief and improvement in vaginal microbial parameters. Reported treatment durations have generally ranged from 7-30 days, with follow-up periods of 15-90 days. Improvements have been described in discharge, pruritus, burning, mal-odour, dyspareunia, inflammation and lower backache.
|
Intervention |
Reported therapeutic potential |
|
Neem (Azadirachta indica) |
Nimbadi Yoni Varti and neem-bark decoction (Nimba Twak Kashaya) have been associated with symptomatic improvement. Constituents such as nimbin, nimbidin, tannins and flavonoids demonstrate antimicrobial activity in experimental studies. |
|
Triphala-based preparations |
Triphaladi Yoni Varti and Triphala Kwatha irrigation have been associated with symptom improvement and favourable changes in vaginal pH and microbial parameters. |
|
Dhatakyadi Varti |
Promising outcomes and lower recurrence than a comparator vaginal suppository were reported in VVC. Its safety and efficacy during pregnancy require confirmation in larger, rigorous studies. |
|
Curcumin and dill seed formulations |
A randomised controlled trial evaluating 10% curcumin and dill-seed curcumin vaginal creams reported good tolerability and relatively few adverse effects. Carvone and limonene in dill seeds have been investigated for potential antifungal activity. |
|
Myrtus communis and Quercus infectoria |
A polyherbal vaginal suppository was investigated for trichomoniasis-associated vaginitis. Gallic acid and hydrolysable tannins may contribute to antimicrobial effects, although clinical efficacy requires stronger confirmation. |
|
Cymbopogon olivieri and garlic |
Studies in BV reported clinical improvements with vaginal capsules and garlic tablets, with outcomes described as comparable to metronidazole. Garlic-derived allicin and plant phenolic compounds have demonstrated antimicrobial activity in experimental settings. |
|
Panchavalkala Kashaya |
This five-plant formulation demonstrated activity against vaginal pathogens in laboratory studies. Synergistic antimicrobial and tissue-healing effects have been proposed. |
Other preparations, including Eladi Kwath, Madhukadi Churna and Rohitaka Mula Churna, have been associated with improvements in nonspecific vulvovaginitis or Shwetapradara. Kasisadi gel, Pushyanuga Churna and medicated tampons containing Brihat Shatavari Ghrita have also been investigated. These findings remain preliminary and should not be interpreted as proof of efficacy against all causes of vaginitis.
Potential mechanisms of action
Herbs traditionally characterised by Kashaya (astringent) and Tikta (bitter) tastes, Laghu (light) and Ruksha (dry) properties, and Krimighna (antimicrobial), Kandughna (itch-relieving), Shothahara (anti-inflammatory) and Vranaropaka (wound-healing) actions have been explored for their potential relevance to vaginal infections.
These traditional classifications have been complemented by investigations of antimicrobial, antifungal and anti-inflammatory activities. Local formulations may provide direct exposure at the affected site, potentially improving symptom control. Nevertheless, improvements in vaginal pH or discharge alone do not establish pathogen eradication or restoration of a healthy vaginal microbiome.
Safety considerations and future directions
Although lower recurrence rates have been reported in some studies, direct comparisons with conventional treatments remain limited. Intravaginal herbal preparations may cause irritation, allergic reactions or disruption of vaginal microbiota, particularly when formulations are inadequately standardised. Vaginal irrigation and unverified products should be avoided because their safety is uncertain. Pregnancy warrants additional caution, and no preparation should be assumed safe solely because it is traditionally used. Diagnosis should be established before treatment because BV, VVC and trichomoniasis require different management approaches. Evidence-based antimicrobial treatment remains essential, particularly for sexually transmitted infections. Persistent or recurrent symptoms require reassessment rather than repeated empirical use of herbal preparations.
Conclusion
Ayurvedic and herbal interventions, including neem, Triphala, Dhatakyadi Varti and Panchavalkala Kashaya, demonstrate potential for alleviating vaginitis-associated symptoms and, in some studies, improving microbiological parameters. However, the available evidence is heterogeneous, and laboratory findings cannot independently establish clinical effectiveness. Standardised formulations, adequately powered clinical trials, longer follow-up and systematic safety assessments are needed to determine their therapeutic role. These interventions should be considered investigational or complementary options where appropriate, without delaying accurate diagnosis or established treatment.2,3
References:
- Jadhav VK, Agrawal T, Monika, et al. Therapeutic potential of Ayurvedic and herbal interventions in vaginitis: a critical narrative review. J Ayurveda Holist Med. 2026;14(8):85-96. https://jahm.co.in/index.php/jahm/article/view/2870
- Shazamani S, Begum W, Sumaiya S. Therapeutic potential of Murmakki (Commiphora myrrha) in gynaecological disorder: a Unani review. J Drug Deliv Ther. 2022;12(4):227-230. https://jddtonline.info/index.php/jddt/article/view/5554/4813
- Shingde SS, Dalvi PN. Effect of Bhumyamalaki Churna with Tandulodaka in the management of Kaphaj Yonivyapad: a literary review. World J Pharm Res. 2025;14(18):228-233. https://wjpr.s3.ap-south-1.amazonaws.com/article_issue/3462ba7de0c1783795f3d54dd514c275.pdf